Herein, to conclusively address the role of mTOR in PRL-3 signalling, we thoroughly examined the correlation of PRL-3 with mTOR activity in: 1) human clinical cancer samples, 2) a mouse model of spontaneous mammary tumour development, and 3) a panel of transgenic tumour cell lines. Here, PTP4A3 is linked to neoplasm.